iHuman Q4 Adj. EPADS $0.09 Down From $0.11 YoY, Sales $35.27M Down From $37.80M YoY
Portfolio Pulse from Benzinga Newsdesk
iHuman reported a decrease in both adjusted earnings per share and sales for Q4, with earnings dropping to $0.09 from $0.11 YoY and sales falling to $35.27M from $37.80M YoY.
February 29, 2024 | 6:16 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
iHuman's Q4 earnings report shows a decline in both adjusted EPS and sales compared to the same period last year.
The reported decrease in both adjusted earnings per share and sales for iHuman indicates a negative performance trend, which is likely to impact investor sentiment and potentially lead to a short-term decrease in stock price.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100